Apo-state structure of the metabotropic glutamate receptor 5 transmembrane domain obtained using a photoswitchable ligand
- PMID: 40521617
- PMCID: PMC12168131
- DOI: 10.1002/pro.70104
Apo-state structure of the metabotropic glutamate receptor 5 transmembrane domain obtained using a photoswitchable ligand
Abstract
Metabotropic glutamate receptor 5 (mGlu5) is implicated in various neurodegenerative disorders, making it an attractive drug target. Although several ligand-bound crystal structures of mGlu5 exist, their apo-state crystal structure remains unknown. Here, we study mGlu5 structural changes using the photochemical affinity switch, alloswitch-1, in combination with time-resolved freeze-trapping methods. By X-ray crystallography, we demonstrated that isomerizing alloswitch-1 leads to its release from the binding pocket within a few seconds. The apo structure, determined at a resolution of 2.9 Å, is more comparable to the inactive state than to the active state. Our approach presents an accessible alternative to time-resolved serial crystallography for capturing thermodynamically stable transient intermediates. The mGlu5 apo-structure provides molecular insights into the ligand-free allosteric pocket, which can guide the design of new allosteric modulators.
Keywords: GPCR; X‐ray crystallography; apo‐state; light activation.
© 2025 The Author(s). Protein Science published by Wiley Periodicals LLC on behalf of The Protein Society.
Conflict of interest statement
Some authors are employees of LeadXpro Biotech AG, a company offering services for GPCR drug design and develops own lead compounds. The other authors declare no financial interests.
Figures


Similar articles
-
A photoswitchable positive allosteric modulator to control the activation of the metabotropic glutamate receptor 5 by light.Biochem Pharmacol. 2025 Oct;240:117065. doi: 10.1016/j.bcp.2025.117065. Epub 2025 Jun 24. Biochem Pharmacol. 2025. PMID: 40571212
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Pharmacological characterisation of allosteric modulators at human mGlu5.Biochem Pharmacol. 2025 Sep;239:117030. doi: 10.1016/j.bcp.2025.117030. Epub 2025 Jun 6. Biochem Pharmacol. 2025. PMID: 40482840
-
Brexanolone, zuranolone and related neurosteroid GABAA receptor positive allosteric modulators for postnatal depression.Cochrane Database Syst Rev. 2025 Jun 26;6(6):CD014624. doi: 10.1002/14651858.CD014624.pub2. Cochrane Database Syst Rev. 2025. PMID: 40562419 Free PMC article. Review.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- Callender R, Dyer RB. Probing protein dynamics using temperature jump relaxation spectroscopy. Curr Opin Struct Biol. 2002;12(5):628–633. - PubMed
-
- Christopher JA, Orgován Z, Congreve M, Doré AS, Errey JC, Marshall FH, et al. Structure‐based optimization strategies for G protein‐coupled receptor (GPCR) allosteric modulators: a case study from analyses of new metabotropic glutamate receptor 5 (mGlu5) x‐ray structures. J Med Chem. 2019;62(1):207–222. - PubMed
-
- Doré AS, Okrasa K, Patel JC, Serrano‐Vega M, Bennett K, Cooke RM, et al. Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain. Nature. 2014;511(7511):557–562. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources